This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Peters WB, Ross M, Vredenburgh et al. High dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993; 11: 1132–1143.
Darling R, Roughton F . The effect of methemoglobin on the equilibrium between oxygen and hemoglobin. Am J Physiol 1942; 137: 265.
Coleman MD, Coleman NA . Drug-induced methemoglobinemia. Treatment issues. Drug Saf 1996; 14: 394.
Matthews PJ . CO-oximetry. Respir Care Clin N Am 1995; 1: 47–68.
Tew KD, Colvin M, Chabner BA . Alkylating agents. In: Chabner BA, Longo DL (eds). Cancer Chemotherapy and Biotherapy. Lippincot-Raven: Philadelphia, 1996, pp 297–332.
Gurtoo HL, Marinello AJ, Struck RF . Studies on mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites. J Biol Chem 1981; 256: 11691–11701.
Freidman HS, Colvin OM, Aisaka K et al. Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity. Cancer Res 1990; 50: 2455–2462.
Hadjiliadis D, Govert JA . Methemoglobinemia after infusion of ifosfamide chemotherapy. Chest 2000; 118: 1208–1210.
Nakao I, Harashima S, Narui T et al. Two cases of methemoglobinemia caused by anti-cancer drugs [in Japanese]. Rinsho Ketsucki 1978; 18: 246–251.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shehadeh, N., Dansey, R., Seen, S. et al. Cyclophosphamide-induced methemoglobinemia. Bone Marrow Transplant 32, 1109–1110 (2003). https://doi.org/10.1038/sj.bmt.1704278
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704278